Pharmacological rate control of atrial fibrillation

Leonardo J. Tamariz, Eric B Bass

Research output: Contribution to journalArticle

Abstract

To control ventricular rate in patients with AF, physicians should seek to control heart rate at rest and with exertion. The goal has to be achieved while minimizing costs and adverse effects. For emergency use, IV diltiazem or esmolol are drugs useful because of their rapid onset of action. They have to be used with caution in patients with concomitant left ventricular failure symptoms, however. For most patients with AF, chronic control of the ventricular rate can be achieved with one drug. For the chronic control of ventricular rate in patients with AF and normal ventricular function, diltiazem, atenolol, are metoprolol are probably the drugs of choice. For patients with AF and structurally abnormal hearts, atenolol, metoprolol, or carvedilol are appropriate choices. Adequate ventricular rate control by pharmacological agents should be evaluated by either 24-hour Holter monitoring or a submaximal stress test to determine the resting and exercise ventricular rate. If the mean ventricular rate is not close to 80 beats per minute, or the heart rate on moderate exertion is not between 90 to 115 beats per minute, a second agent to control the rate should be added. Excessive reductions in ventricular rates that could limit exercise tolerance should be avoided.

Original languageEnglish (US)
Pages (from-to)35-45
Number of pages11
JournalCardiology Clinics
Volume22
Issue number1
DOIs
StatePublished - Feb 2004

Fingerprint

Atrial Fibrillation
Pharmacology
Metoprolol
Atenolol
Diltiazem
Heart Rate
Pharmaceutical Preparations
Ambulatory Electrocardiography
Exercise Tolerance
Ventricular Function
Exercise Test
Emergencies
Exercise
Physicians
Costs and Cost Analysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Pharmacological rate control of atrial fibrillation. / Tamariz, Leonardo J.; Bass, Eric B.

In: Cardiology Clinics, Vol. 22, No. 1, 02.2004, p. 35-45.

Research output: Contribution to journalArticle

Tamariz, Leonardo J. ; Bass, Eric B. / Pharmacological rate control of atrial fibrillation. In: Cardiology Clinics. 2004 ; Vol. 22, No. 1. pp. 35-45.
@article{2b17e6b1a3e94f4ea6bd11d090c54eb4,
title = "Pharmacological rate control of atrial fibrillation",
abstract = "To control ventricular rate in patients with AF, physicians should seek to control heart rate at rest and with exertion. The goal has to be achieved while minimizing costs and adverse effects. For emergency use, IV diltiazem or esmolol are drugs useful because of their rapid onset of action. They have to be used with caution in patients with concomitant left ventricular failure symptoms, however. For most patients with AF, chronic control of the ventricular rate can be achieved with one drug. For the chronic control of ventricular rate in patients with AF and normal ventricular function, diltiazem, atenolol, are metoprolol are probably the drugs of choice. For patients with AF and structurally abnormal hearts, atenolol, metoprolol, or carvedilol are appropriate choices. Adequate ventricular rate control by pharmacological agents should be evaluated by either 24-hour Holter monitoring or a submaximal stress test to determine the resting and exercise ventricular rate. If the mean ventricular rate is not close to 80 beats per minute, or the heart rate on moderate exertion is not between 90 to 115 beats per minute, a second agent to control the rate should be added. Excessive reductions in ventricular rates that could limit exercise tolerance should be avoided.",
author = "Tamariz, {Leonardo J.} and Bass, {Eric B}",
year = "2004",
month = "2",
doi = "10.1016/S0733-8651(03)00111-5",
language = "English (US)",
volume = "22",
pages = "35--45",
journal = "Cardiology Clinics",
issn = "0733-8651",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Pharmacological rate control of atrial fibrillation

AU - Tamariz, Leonardo J.

AU - Bass, Eric B

PY - 2004/2

Y1 - 2004/2

N2 - To control ventricular rate in patients with AF, physicians should seek to control heart rate at rest and with exertion. The goal has to be achieved while minimizing costs and adverse effects. For emergency use, IV diltiazem or esmolol are drugs useful because of their rapid onset of action. They have to be used with caution in patients with concomitant left ventricular failure symptoms, however. For most patients with AF, chronic control of the ventricular rate can be achieved with one drug. For the chronic control of ventricular rate in patients with AF and normal ventricular function, diltiazem, atenolol, are metoprolol are probably the drugs of choice. For patients with AF and structurally abnormal hearts, atenolol, metoprolol, or carvedilol are appropriate choices. Adequate ventricular rate control by pharmacological agents should be evaluated by either 24-hour Holter monitoring or a submaximal stress test to determine the resting and exercise ventricular rate. If the mean ventricular rate is not close to 80 beats per minute, or the heart rate on moderate exertion is not between 90 to 115 beats per minute, a second agent to control the rate should be added. Excessive reductions in ventricular rates that could limit exercise tolerance should be avoided.

AB - To control ventricular rate in patients with AF, physicians should seek to control heart rate at rest and with exertion. The goal has to be achieved while minimizing costs and adverse effects. For emergency use, IV diltiazem or esmolol are drugs useful because of their rapid onset of action. They have to be used with caution in patients with concomitant left ventricular failure symptoms, however. For most patients with AF, chronic control of the ventricular rate can be achieved with one drug. For the chronic control of ventricular rate in patients with AF and normal ventricular function, diltiazem, atenolol, are metoprolol are probably the drugs of choice. For patients with AF and structurally abnormal hearts, atenolol, metoprolol, or carvedilol are appropriate choices. Adequate ventricular rate control by pharmacological agents should be evaluated by either 24-hour Holter monitoring or a submaximal stress test to determine the resting and exercise ventricular rate. If the mean ventricular rate is not close to 80 beats per minute, or the heart rate on moderate exertion is not between 90 to 115 beats per minute, a second agent to control the rate should be added. Excessive reductions in ventricular rates that could limit exercise tolerance should be avoided.

UR - http://www.scopus.com/inward/record.url?scp=1642545669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642545669&partnerID=8YFLogxK

U2 - 10.1016/S0733-8651(03)00111-5

DO - 10.1016/S0733-8651(03)00111-5

M3 - Article

VL - 22

SP - 35

EP - 45

JO - Cardiology Clinics

JF - Cardiology Clinics

SN - 0733-8651

IS - 1

ER -